Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-007569

CHAIRMAN & CEO sold 65,012 shares at $21.02 ($1,366,552)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Patel Sanj K CHAIRMAN & CEO 2024-03-07 Sale 10b5-1 −65,012 $21.02 $1,366,552 0 I
Open-market sales · 65,012 sh · avg $21.02 · $1,366,552
Loading xslF345X05/form4-03112024_110346.xml…